Pfizer applies for emergency use of Covid-19 vaccine amid testing bottleneck: CNBC After Hours
November 20, 2020 at 18:07 PM EST
Pfizer submitted its Covid-19 vaccine to the FDA for emergency authorization today, kicking off the first step of the approval and deployment process.
